SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001171843-15-003145
Filing Date
2015-05-28
Accepted
2015-05-27 17:46:20
Documents
12
Period of Report
2015-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 40-F f40f_052715.htm 40-F 66575
2 EXHIBIT 99.1 exh_991.htm EX-99.1 663286
3 EXHIBIT 99.2 exh_992.htm EX-99.2 2685896
4 EXHIBIT 99.3 exh_993.htm EX-99.3 756780
5 EXHIBIT 99.4 exh_994.htm EX-99.4 9131
6 EXHIBIT 99.5 exh_995.htm EX-99.5 19746
7 EXHIBIT 99.6 exh_996.htm EX-99.6 8733
8 logo.jpg GRAPHIC 5667
9 kpmg_logo.jpg GRAPHIC 2374
10 kpmg_sig.jpg GRAPHIC 2552
11 structure.jpg GRAPHIC 26885
12 kmpg_hdr.jpg GRAPHIC 12925
  Complete submission text file 0001171843-15-003145.txt   4281237
Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Neptune Technologies & Bioressources Inc. (Filer) CIK: 0001401395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 40-F | Act: 34 | File No.: 001-33526 | Film No.: 15893359
SIC: 2834 Pharmaceutical Preparations